More recently, using CCR5 antagonists, Wang et al. demonstrated the involvement of CCL5/CCR5 signaling in the cross-talk between GC cells and TAMs leading to tumor growth [112], providing an additional link between inflammation and GC. Here, CCR5 is linked to neoplasm.